CDK14 has been implicated in pathobiology of many cancers, including liver, ovarian, breast, gastric, pancreatic, esophageal, glioblastoma and osteosarcoma,444–454 although most of these studies derived from the analyses of cell lines rather than strong evidences from primary tumor samples. Here, CDK14 is linked to neoplasm.